Mariani, Giorgio, et al. “Olanzapine Versus Typical Neuroleptics for Schizophrenia: Evaluation of Social and Economic Costs”. Farmeconomia. Health Economics and Therapeutic Pathways, vol. 7, no. 2, Sept. 2006, pp. 119-24, doi:10.7175/fe.v7i2.681.